Capy Guidebook
Understand the context. Keep the decision with your clinician.
We publish concise explanations for questions people actually ask during a GLP-1 treatment. Every medical or regulatory claim links to a primary source, and no article tells you which medication or dose to take.
How we write about health
- Primary sources first: regulators, public-health agencies and official labeling.
- A visible verification date on every guide.
- No dose conversions, titration plans, product rankings or treatment recommendations.
- Country context stays explicit because approvals and pharmacy rules differ.
- Brand names are used editorially; Capy is independent from their manufacturers.
Latest guides
Built for useful answers,
not search-engine filler.
What to Track During GLP-1 Treatment
A practical, non-prescriptive checklist for organizing GLP-1 doses, symptoms, weight, nutrition, and questions before a healthcare appointment.
Read article →United States · 4 minMounjaro vs. Zepbound in 2026: Same Ingredient, Different FDA-Labeled Uses
Mounjaro and Zepbound both contain tirzepatide, but their FDA-labeled uses are not identical. Here is what that distinction means for accurate records.
Read article →FDA update · 5 minCompounded GLP-1 Products in 2026: What the FDA Says
A concise review of FDA statements about compounded semaglutide and tirzepatide, approval status, dosing-error reports, and changing shortage policies.
Read article →México · 4 minMedicamentos GLP-1 en México: alertas y anuncios irregulares
Cómo consultar información oficial de COFEPRIS sobre medicamentos GLP-1, publicidad irregular, registros y farmacovigilancia en México.
Leer artículo →Brasil · 4 minCanetas GLP-1 no Brasil: retenção da receita em 2026
Entenda a regra da Anvisa para prescrição e dispensação de agonistas GLP-1 no Brasil, sem orientações de dose ou tratamento.
Ler artigo →España y Unión Europea · 4 minMedicamentos GLP-1 por internet en España: qué advierten AEMPS y EMA
AEMPS y EMA alertan sobre medicamentos GLP-1 ilegales vendidos por internet. Aprende a distinguir información oficial de una oferta fraudulenta.
Leer artículo →المملكة العربية السعودية · 4 دقائقأدوية GLP-1 الفموية في السعودية عام 2026: ماذا أعلنت هيئة الغذاء والدواء؟
ملخص محايد لإعلان هيئة الغذاء والدواء السعودية عن تسجيل مستحضر فموي من فئة GLP-1، وما يعنيه ذلك لسجل دوائي دقيق.
اقرأ المقال ←